Synthesis of 2-dialkylaminomethyl-1,4-benzoxathians.
D000317:Adrenergic alpha-Antagonists / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D004147:Dioxins / Q000138:chemical synthesis; D006571:Heterocyclic Compounds / Q000138:chemical synthesis*; D007259:Infrared Rays; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008744:Methylamines / Q000138:chemical synthesis / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010075:Oxathiins / Q000138:chemical synthesis / Q000494:pharmacology; D051381:Rats; D013057:Spectrum Analysis; D013329:Structure-Activity Relationship; D013565:Sympatholytics / Q000138:chemical synthesis*; D014649:Vas Deferens / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004147:Dioxins; D006571:Heterocyclic Compounds; D008744:Methylamines; D010075:Oxathiins; D013565:Sympatholytics